A recent study estimated the economic impact of foodborne campylobacterosis contracted from chicken consumption in Australia to be more than $110 million USD annually, with chicken consumption linked to 30 percent of all Campylobacter infections recorded in the country.
The latest UK Food Security Report (UKFSR) has been published by the UK Government. A trend noted in the report is that, despite Campylobacter causing the most foodborne illnesses, outbreak detection is hindered by the lack of a required national typing scheme.
The EU One Health Zoonoses Report for 2023 shows that foodborne illnesses are rising in the EU, with listeriosis cases reaching their highest levels since 2007. Campylobacter, Salmonella, and Shiga toxin-producing Escherichia coli (STEC) caused the greatest number of illnesses in 2023.
University of Florida (UF) researchers have discovered that a toxin produced by Campylobacter jejuni can accelerate the spread of colon cancer in the human body.
A recent study of genomic data for Campylobacter from 2009–2019 found a steep increase in human infections attributable to poultry, as well as a concerning rise in the proportion of multidrug-resistant isolates. Campylobacter isolates associated with poultry were found to harbor the most antimicrobial resistance (AMR).
Published in CDC’s Emerging Infectious Diseases, one of the largest-ever whole genome sequencing (WGS) analyses of Campylobacter in Africa found antimicrobial resistance (AMR) in 75 percent of human and poultry isolates from Tanzania and Kenya.
Osaka Metropolitan University researchers have developed an antibody that can identify Campylobacter jejuni and inhibit its growth, which could potentially power rapid detection solutions for food contamination and medical interventions for foodborne illness.
A recent study has demonstrated that current sampling and testing methods for Campylobacter may overlook epidemiologically-important strains. The researchers suggest using optimized culture methods and analyzing multiple isolates per sample.
A recent study conducted by researchers at NC State University has found a significantly higher prevalence of Campylobacter on backyard poultry farms than on commercial poultry farms, although the rates of antimicrobial resistance (AMR) were much higher among isolates from commercial farms.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA-FSIS) has selected bioMérieux’s GENE-UP® CAMPYLOBACTER assay for
use in its Field Service Laboratories.